Sign in to Peak Brain Path
Sign in to access your courses, books, and progress tracker. New here? Signing in creates your account automatically.
Want to explore courses first?
Browse courses and booksSign in to access your courses, books, and progress tracker. New here? Signing in creates your account automatically.
Want to explore courses first?
Browse courses and booksModule 11
Chapter 11 · 2 h · 8 quiz items · pass at 80%
BCIA Domain VI opens with the intake, where scope of practice is decided in real time. This module teaches the practitioner to take a complete neurofeedback history, to recognize the absolute contraindications and the referral gates, and to stay inside the assessment limits of the BCN and BCN-L routes. Because getting scope wrong is a professional risk, the quiz requires solid command of referral gates and contraindications.
Before you place a single electrode, you have a conversation. The intake is where you decide whether this person belongs in your chair at all, what you are allowed to assess given your credential and license, what you are going to train and why, and how you will know later whether it worked. Practitioners who skip or rush it pay for it twice: once when a contraindication they never asked about surfaces mid-course, and again when a client asks "is this helping?" and there is no baseline to answer with. The intake is not paperwork you get out of the way so the real work can start. It is the first clinical act, and the quality of everything downstream depends on it.
This chapter walks the intake in the order you will actually run it: scope of practice and the referral gates that come before anything else, the structure of a neurofeedback intake, the symptom inventories you choose from and why, the contraindications you screen for, the psychoeducation conversation and the consent it leads to, the basics of insurance documentation, and the outcome measures that turn "the client feels better" into something you can defend. The throughline is that assessment is not a single event at the start. It is a loop: baseline, train, re-measure, decide. This chapter sets up the baseline; Chapter 12 covers the brain map; Chapter 20 closes the loop with progression and outcome monitoring.
The first question is not clinical. It is jurisdictional: what are you, by credential and by license, permitted to do with the person in front of you? Get this wrong and the most careful assessment in the world is a liability.
Board Certification in Neurofeedback (BCN) certifies that you have met the BCIA training, mentorship, and examination standards covered throughout this book. It does not, by itself, confer the legal authority to diagnose. That authority comes from a clinical license (psychology, medicine, counseling, social work, nursing, and others), and the distinction between a BCN who holds such a license and one who does not is the distinction the field marks informally as BCN versus BCN-L (licensed). The line matters because it determines the language you may use and the claims you may make.
A licensed practitioner working within their scope can diagnose, can use diagnostic language in the record, and can position neurofeedback as a treatment for a diagnosed condition where their license and the evidence support it. A non-licensed BCN cannot diagnose, full stop. What a non-licensed practitioner can do is real and useful: conduct a thorough intake, administer and score standardized inventories, observe and describe patterns, train toward regulatory goals, track outcomes, and coordinate with the licensed clinicians who carry the diagnostic authority. The work is framed around regulation and training rather than around diagnosis and cure. You are helping a brain regulate, not treating a disease you named.
The practical translation is a vocabulary discipline. A non-licensed practitioner says "your intake and inventory scores are consistent with the kind of attention-regulation difficulty that often shows up as elevated frontal slow activity, which is what this training targets." They do not say "you have ADHD and neurofeedback treats it." The first is description and training rationale; the second is diagnosis and a treatment claim, and it is outside a non-licensed scope. When you are unsure which side of the line a sentence falls on, that uncertainty is itself the answer: route it to the licensed clinician, or reframe it as description. Chapter 23 develops scope of practice, diagnostic language, and the ethics that govern both in full; for the intake, the rule is to know your scope before the client arrives and to build your intake language inside it.
Neurofeedback rarely happens in isolation, and it should not. Most clients arrive already inside a treatment system: a prescriber managing medication, a therapist doing the talking work, a physician managing a medical condition. Your job is to be part of that team, not a silo that runs parallel to it and never talks to it.
Two referral directions matter. Inbound, you want to know who sent the client and who else is treating them, and you want a release of information that lets you talk to those clinicians. A client on a stimulant, an antidepressant, or a benzodiazepine is bringing a pharmacologically shaped brain to your assessment, and you need the prescriber in the loop both to interpret what you record and to coordinate when training changes the client's response to the medication (Chapter 10 covered why that happens). Outbound, you refer when the presentation calls for something outside your competency or your scope. A client describing symptoms that suggest an undiagnosed medical or psychiatric condition needs evaluation by someone licensed to provide it before, or alongside, training. A client whose presentation includes active suicidality, psychosis, or a possible seizure disorder needs the appropriate specialist, and some of those are gates that hold training entirely until they are addressed.
The coordination is not a courtesy. It is part of competent assessment. The prescriber's medication list changes how you read the brain map. The therapist's formulation tells you what else is moving in the client's life when symptoms shift. The physician's workup rules out the medical cause that neurofeedback would otherwise chase fruitlessly. Build the releases into your intake paperwork, and treat the surrounding clinicians as collaborators whose information sharpens your own.
The intake itself is a structured history with a neurofeedback-specific emphasis. A general clinical intake gathers presenting problem, history, and context; a neurofeedback intake adds the elements that bear on what you will record, what you will train, and what could go wrong. Run it as a conversation with a checklist behind it, not an interrogation, but make sure the checklist gets covered.
The core domains:
Presenting problem and goals. What brought the client in, in their own words, and what specifically they want to change. "I can't focus at work" and "I want to stop snapping at my kids" are more useful than "ADHD" or "anxiety," because they name the functional target you will track. Get the client's own goal stated concretely enough to measure later.
History of the presenting problem. Onset, course, what makes it better or worse, what they have already tried. A problem present since early childhood reads differently than one that started after a car accident or a divorce.
Developmental and medical history. Birth and developmental milestones where relevant (especially for pediatric attention presentations), head injuries (concussions matter for both interpretation and protocol), seizures or seizure-like events, current medical conditions, and current medical care.
Medication and substance history. Every prescription and over-the-counter medication, dose, and how long they have been on it; caffeine, nicotine, alcohol, cannabis, and other substance use, with rough quantity and pattern. This is not optional and it is not a place to be squeamish. Medication and substances shape the EEG you are about to record, and an undocumented stimulant taken the morning of a brain map will send you in the wrong direction. Document the timeline.
Prior treatment. Previous neurofeedback, therapy, medication trials, and their results. A client who has done neurofeedback before brings expectations and a history of response or non-response that informs your plan.
Sleep. Ask about sleep specifically and early, because poor sleep mimics and worsens almost everything a neurofeedback client comes in for. A client sleeping five broken hours a night looks like a client with an attention disorder on both behavior reports and the brain map, and training attention before addressing the sleep is training against a confound. Make sleep evaluation part of the intake rather than an afterthought.
Contraindication screen. The specific safety questions covered in 11.5, asked directly rather than left to emerge.
The output of the intake is not just a filled form. It is a working clinical picture: what the client wants, what is driving it, what else is going on that could explain or complicate it, and whether anything in the history gates or shapes training. That picture is the hypothesis you carry into the brain map and the protocol decision.
A structured interview gives you depth; standardized inventories give you comparability and a number you can track. You want both. The inventory turns a client's report into a score that can be compared to a normative sample and, more importantly, re-administered later to measure change. The choice of inventory falls along a useful axis: broadband instruments that survey many domains at once, and targeted instruments that go deep on a single presentation.
Broadband inventories cast wide. They sample mood, anxiety, attention, somatic complaints, and more in a single administration, which is what you want at intake when you are still forming the clinical picture and do not yet know where the problem concentrates. For children and adolescents, the Behavior Assessment System for Children (BASC) and the Child Behavior Checklist (CBCL) are the workhorses, each gathering a broad behavioral and emotional profile from parent, teacher, and (age permitting) self-report. For adults, broadband symptom checklists such as the SCL-90 survey a wide range of psychological symptoms in one instrument. The strength is coverage: a broadband measure catches the anxiety riding alongside the attention complaint, or the mood component the client did not mention. The cost is depth: a broadband instrument tells you a domain is elevated, not the fine structure of why.
Targeted inventories go deep on one presentation. For attention, the Conners scales (parent, teacher, self-report forms) are the standard, profiling the specific dimensions of inattention, hyperactivity, and impulsivity in detail. For post-traumatic presentations, the PTSD Checklist (PCL-5) tracks symptom clusters against the diagnostic criteria. For depression and anxiety, focused scales give you a sensitive, re-administrable measure of that one dimension. The strength is sensitivity: a targeted scale moves when the thing you are training moves, which makes it a better outcome tracker. The cost is tunnel vision: a targeted scale will not catch the comorbidity sitting outside its frame.
The "QEEG-targeted" framing deserves a note, because it is where this book's assessment logic connects. Some inventories map more naturally onto the phenotype and arousal thinking that drives protocol selection. An attention inventory that distinguishes inattentive from hyperactive-impulsive presentations, or an instrument that separates somatic from cognitive anxiety, gives you information that points toward a protocol direction (the underaroused-versus-overaroused sort from Chapter 13) more directly than a global distress score does. The practical pattern most practitioners settle into: a broadband instrument at intake to map the territory, plus one or two targeted instruments on the presentations that matter most for this client, re-administered across the course as outcome measures. You are not trying to give every test. You are trying to establish a baseline you can defend and re-measure.
Neurofeedback has a strong safety profile. Across controlled studies and a much larger body of clinical practice, serious adverse events clearly attributable to neurofeedback are essentially absent, and the professional bodies that oversee the field converge on calling it low-risk when competently administered. That safety record is real, and it is also exactly why the contraindication screen matters: the risk is low precisely because competent practitioners screen for the situations where it is not, rather than training everyone who walks in.
Treat a short list as gates that hold training until they are addressed:
Active psychosis or acute mania. These are states where the brain needs stabilization, usually pharmacological, before the kind of regulatory training neurofeedback provides. Neurofeedback has been studied as an adjunct alongside antipsychotic medication with reasonable safety data, but it is not a first-line intervention for someone in acute crisis. A client who is actively psychotic or acutely manic at intake is not a candidate for training until that state is managed by the appropriate clinician.
Active suicidality or self-harm. The priority is safety-focused intervention by someone equipped to provide it. Neurofeedback belongs in the longer-term plan once acute risk is managed, not in the middle of an acute crisis.
Unstable seizure disorders. Neurofeedback grew out of epilepsy research, and SMR training was originally used to raise seizure thresholds, so the relationship is not one of simple prohibition. But training without proper assessment, or with protocols that increase excitability rather than stability, can lower thresholds. Seizure-involved training is specialist work; a generalist practitioner who encounters a client with an unstable or undiagnosed seizure disorder refers rather than trains.
Implanted electrical devices. Standard EEG recording is safe for most implants, but some devices, certain pacemakers and deep brain stimulators among them, can interact with EEG equipment. The rule is full disclosure and, where there is any doubt, clearance from the managing physician before recording. Ask specifically; do not assume a client will volunteer it.
Two further situations call for caution rather than a hard gate. Heavy sedation, from benzodiazepines or opioids at high doses, can blunt the brain's responsiveness to feedback, because the operant learning the training depends on requires a brain plastic enough to respond to reinforcement. This does not rule out training, but it shapes expectations and may shift sequencing. And acute, unmanaged medical conditions that could explain the presentation belong in a physician's hands before or alongside training. None of these are blanket rules applied mechanically; they are flags for clinical judgment, and the judgment is to assess each situation individually and route what is outside your scope to who can handle it. When a contraindication is present, the correct move is not to push through; it is to refer, to coordinate, and to revisit training once the gating condition is addressed.
Once the client is cleared and you have a working picture, you explain what neurofeedback is, what you are proposing to do, and what they can realistically expect. This conversation is not a sales pitch and it is not a disclaimer read aloud. It is the moment you set the expectations that determine whether the client stays engaged through the unglamorous middle of a training course, and it is the foundation that informed consent is built on.
Say what neurofeedback is in plain terms: a form of training in which the brain's own electrical activity is measured and fed back in real time, so the brain can learn, through repetition and reinforcement, to shift the patterns associated with the client's difficulty. It is learning, not a procedure done to a passive recipient, and it takes the time that learning takes. Frame the mechanism honestly as operant conditioning of brain activity rather than as a treatment that fixes a broken part.
Be specific and honest about timelines and outcomes. Most training courses run on the order of twenty to forty sessions depending on the presentation, and progress is individual: some clients respond faster, some slower, and a meaningful minority do not get the response they hoped for even in experienced hands. Say that. Frame any timeline as an approximation, not a promise. The single most damaging thing you can do in this conversation is overclaim, because the client who was promised a cure and got partial improvement feels like a failure when the result was actually a reasonable outcome.
The discipline here is what not to promise. Do not guarantee a cure or a specific outcome. Do not promise elimination of a condition. Do not claim the device is FDA-approved to treat a specific psychiatric condition, because neurofeedback devices are generally cleared as biofeedback devices for relaxation rather than approved for specific disorders, and the distinction matters legally and ethically. Do not let enthusiasm outrun the evidence. For many of the conditions clients bring, neurofeedback is not yet a first-line, guideline-endorsed treatment, even where clinical experience is more favorable than the published evidence, and an honest practitioner names that gap rather than papering over it. The conversation that sets accurate expectations is the one that produces a client who can tell whether the training is working, which is the client you want.
The psychoeducation conversation becomes consent when it is documented and the client agrees on the basis of accurate information. Consent is not a signature on a form; it is a process the form records. A defensible neurofeedback consent covers, at minimum:
On side effects, the client should know what is normal so they do not panic at it and do report what matters. Neurofeedback's transient effects are mild and self-limiting: some clients feel tired after sessions, especially early in training; mild headache occurs occasionally and usually resolves with hydration and rest; irritability is the most common early effect, as the brain is asked to change a long-running pattern, and it typically settles within the first week or two. Sleep can shift, sometimes improving immediately, sometimes with a night or two of disruption first. With deep-state and trauma-oriented protocols, emotional activation can surface, which is often a sign of processing rather than harm but should be discussed so you can calibrate. The key pattern to convey: these effects are acute, happening during or the same day as a session and resolving quickly, and the client should report anything that escalates rather than settles, anything that persists across sessions, or any destabilizing emotional response, so you can adjust. Consent framed this way is not defensive paperwork; it is the client understanding the deal well enough to be a partner in it.
Neurofeedback is predominantly an out-of-pocket service, and the documentation realities follow from that. Insurance coverage is patchy and inconsistent: some commercial insurers reimburse under biofeedback procedure codes, while many classify neurofeedback as investigational or not medically necessary and decline it. The point for the intake is not to master billing, which is its own specialty and varies by payer and jurisdiction, but to understand what documentation supports a claim where coverage exists and to be transparent with clients about cost regardless.
Where insurance may apply, the documentation that supports it is the same documentation that supports good clinical practice: a clear statement of the presenting problem and its functional impact, standardized assessment results that establish a baseline and quantify severity, a treatment plan with stated goals, and ongoing notes that track progress against those goals with objective measures. Biofeedback procedure codes exist and are the usual route when a claim is submitted, but a claim without the supporting clinical documentation, the baseline, the plan, the measured outcomes, is a claim that does not hold up. The diagnostic component of that documentation belongs to the licensed clinician; a non-licensed practitioner contributes the assessment data, the training record, and the outcome tracking, and coordinates with whoever carries the diagnosis.
Be transparent about cost as part of consent, because most clients are paying directly. Tell them what sessions cost, what the brain map costs, what a full course is likely to run, and whether there are reassessment checkpoints where they can stop. Avoid the practice the field rightly criticizes: large prepaid packages with no built-in reassessment, which convert a clinical relationship into a sales transaction and remove the client's off-ramp. Whatever the payment structure, the documentation that makes it defensible is the same documentation that makes the clinical work sound.
Assessment does not end at intake. The reason you establish a baseline is to measure against it, and a practice that does not track outcomes has no way to know whether its training works, which means neither does the client. Outcome tracking runs on two channels, objective and subjective, and you want both because each catches what the other misses.
Objective measures are administered tests and quantified data that do not depend on how the client feels on a given day. The continuous performance test (CPT) is the workhorse for attention: the client responds to targets over a sustained, deliberately boring task, and the test quantifies omissions (missed targets, a marker of inattention), commissions (responses to non-targets, a marker of impulsivity), and reaction-time variability (inconsistency, often the most sensitive attention marker). The Test of Variables of Attention (TOVA) is a widely used CPT with normative comparison; other CPTs serve the same function. Administered at baseline and again across the course, a CPT gives you a hard number for attention change that a client's self-report cannot. The standardized behavioral inventories double as objective-leaning outcome measures when re-administered: the BASC and CBCL for children, with their parent and teacher reports, capture change observed by people other than the client, which matters especially for pediatric clients who under-report their own difficulties. And a QEEG re-assessment is the brain-level objective measure, comparing the trained brain to its own baseline (Chapter 12 and Chapter 20 cover re-mapping timing).
Subjective measures are the client's own report, structured so it can be tracked. Re-administered symptom scales (the targeted inventories from 11.4, given again at intervals) turn the client's experience into a trend line. Session logs, in which the client notes between-session changes in the functional target, capture the day-to-day movement the formal scales sample only periodically. Sleep diaries are worth their weight for any presentation where sleep is in play, because sleep change often precedes and predicts symptom change, and because a sleep diary catches the confound (the client whose attention "improved" the week they finally slept). Subjective measures are not soft data to be discounted; they are the client's functional reality, and a course that moves a CPT score but leaves the client feeling no different has not succeeded.
The two channels work together. Convergence between them, a CPT that improves alongside a client who reports sharper focus and a parent who reports better homework completion, is strong evidence the training is working. Divergence, an improved test score with no felt change or vice versa, is a signal to look closer: a confound, a measurement artifact, or a deviation that was never the functional problem. Track both, compare them, and let the comparison guide the decision to continue, adjust, or stop.
The record is what makes the whole intake defensible, reconstructable, and clinically useful months later when you, a supervisor, a BCIA mentor, or another provider needs to know what you did and why. A neurofeedback practice record should let someone reconstruct the clinical reasoning and the course of training without having to ask you.
At minimum, the record holds the intake (history, medications, contraindication screen, the working clinical picture), the consent (the documented agreement and what the client was told), the baseline assessment data (inventory scores, CPT results, the brain map if one was done), the treatment plan (the protocol chosen, the rationale, the goals, the expected change and timeline), the session-by-session notes (what was run, how the client responded, relevant observations), the outcome tracking (the objective and subjective measures across the course), and the reassessment results (re-administered measures and re-maps that document change). The standard to aim for is specificity over summary: "client doing well" is not a record; "Conners inattention T-score from 72 at baseline to 61 at session 20, parent reports homework completed without prompting, CPT omissions improved from the 9th to the 34th percentile" is. The first tells a reader nothing they can act on; the second lets anyone reconstruct exactly where the client was and where they are.
Two practical disciplines keep the record honest. Document medication status and changes throughout, not just at intake, because a medication change mid-course shifts both the EEG and the symptoms and you need the record to show what moved when. And keep the documentation contemporaneous: notes written at the time of the session, not reconstructed weeks later from memory, which is both more accurate and more defensible. The record is not a chore separate from the clinical work; it is the clinical reasoning made durable.
Strip this chapter to what you do before training starts. You establish your scope, knowing what your credential and license let you assess and say, and you build your intake language inside it. You gather the surrounding clinicians and the releases that let you coordinate with them. You take a structured history with the neurofeedback-specific emphases, medications, sleep, head injuries, prior treatment, and you screen the contraindication gates directly rather than waiting for them to surface. You choose a broadband inventory to map the territory and targeted inventories to track what matters, and you administer them as a baseline. You have the psychoeducation conversation honestly, set expectations you can keep, and turn that conversation into documented consent. You establish objective and subjective outcome measures so the loop can close later. And you write it all down with enough specificity that the record reconstructs your reasoning.
For the BCN exam, hold the structure. Know that a non-licensed BCN cannot diagnose and that diagnostic authority rides with a clinical license, and know the vocabulary discipline that follows: description and training rationale, not diagnosis and cure. Know the absolute contraindications, active psychosis, acute mania, active suicidality, unstable seizure disorders, implanted electrical devices, as the situations that gate training until addressed, and know that heavy sedation and unmanaged medical conditions call for caution and coordination. Know that sleep is the confound to screen for before training attention. Know the required elements of neurofeedback informed consent, including the explicit disclosure of possible non-response and the honest statement of evidence status. Know the difference between broadband inventories (BASC, CBCL, SCL-90) and targeted inventories (Conners, PCL-5), and know the objective outcome measures (CPT and TOVA, re-administered behavioral inventories, QEEG re-assessment) that turn felt improvement into a number you can defend. The intake is the first clinical act, and on the exam as at the chair, it is graded on whether you screened, scoped, baselined, and documented before you ever set a threshold.